Please enable JavaScript.
Coggle requires JavaScript to display documents.
ASCO (2018 (metastatski (stratifikacija (HR+ (The PI3K-AKT-mTOR Pathway:…
ASCO
2018
metastatski
stratifikacija
HR+
The PI3K-AKT-mTOR Pathway: Are We Making Headway?
https://www.vivindatv.com/content/vivinda/en/econgress/events/2018-asco-annual-meeting/breast-cancer/breast-cancer_metastatic_10829/the-pi3k-akt-mtor-pathway--are-we-making-headway-_161530.html
Present and Future of CDK Inhi
https://www.vivindatv.com/content/vivinda/en/econgress/events/2018-asco-annual-meeting/breast-cancer/breast-cancer_metastatic_10829/present-and-future-of-cdk-inhibitors_161480.html
TN
Chemotherapy With a Twist
https://www.vivindatv.com/content/vivinda/en/econgress/events/2018-asco-annual-meeting/breast-cancer/breast-cancer_metastatic_10829/her2-negative-metastatic-breast-cancer--chemotherapy-with-a-twis_161527.html
Local/Regional/Adjuvant
stratifikacija
Less is More: Opportunities to De-escalate Therapy
https://www.vivindatv.com/content/vivinda/en/econgress/events/2018-asco-annual-meeting/breast-cancer/breast-cancer_local-regional-adjuvant_10830/less-is-more--opportunities-to-de-escalate-therapy_165781.html
Unlocking the Curative Potential of the Endocrine Axis
https://www.vivindatv.com/content/vivinda/en/econgress/events/2018-asco-annual-meeting/breast-cancer/breast-cancer_local-regional-adjuvant_10830/unlocking-the-curative-potential-of-the-endocrine-axis_161595.html
program
https://am.asco.org/sites/am.asco.org/files/AM18-Program-Full.pdf